Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1660-1663

  Sugar, Alan M ^a   Liu, Xiu Ping ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DEOXYCHOLATE SODIUM; DRUG VEHICLE; ITRACONAZOLE; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CELL CULTURE; MALE; MORTALITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0031749355     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515319     Document Type: Article

References (15)

1. Sugar AM. Use of amphotericin B with azole antifungal drugs: What are we doing? Antimicrob Agents Chemother 1995;39:1907-12.
2. Maesaki S, Kohno S, Kaku M, Koga H, Hara K. Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother 1994;38:2843-5.
3. Martin E, Maier F, Bhakdi S. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Antimicrob Agents Chemother 1994;38:1331-8.
4. Vazquez J, Arganoza M, Vaishampayan J, Akins R. In vitro interaction between amphotericin B and azoles in Candida albicans. Antimicrob Agents Chemother 1996;40:2511-6.
5. Sugar AM, Hitchcock CA, Troke PF, Picard M. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob Agents Chemother 1995;39:598-601.
6. Atkinson BA, Bocanegra R, Colombo AL, Graybill JR. Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B. Antimicrob Agents Chemother 1994;38:1604-7.
7. George D, Kordick D, Miniter P, Patterson TF, Andriole VT. Combination therapy in experimental invasive aspergillosis. J Infect Dis 1993;168:692-8.
8. Sanati H, Ramos C, Bayer A, Ghannoum M. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Antimicrob Agents Chemother 1997;41:1345-8.
9. Sugar AM. Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyeneazole combination. Antimicrob Agents Chemother 1991;35:1669-71.
10. Sugar AM, Salibian M, Goldani LZ. Saperconazole therapy of murine disseminated candidiasis: efficacy and interactions with amphotericin B. Antimicrob Agents Chemother 1994;38:371-3.
11. Scheven M, Schwegler F. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro. Antimicrob Agents Chemother 1995;39:1779-83.
12. Schaffner A, Frick PG. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis 1985;151:902-10.
13. Schmitt HJ, Bernard EM, Edwards FF, Armstrong D. Combination therapy in a model of pulmonary aspergillosis. Mycoses 1991;34:281-5.
14. Albert MM, Graybill JR, Rinaldi MG. Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination. Antimicrob Agents Chemother 1991;35:1721-5.
15. Anaissie EJ, Hachem R, Karyotakis NC, et al. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 1994;38:2541-4.